Skip to main content

2 Result(s)

within English Remove this filter Hematology Remove this filter Oncology Remove this filter T Cluzeau Remove this filter

and
Your search also matched 3 preview-only Content is preview-only when you or your institution have not yet subscribed to it.

By making our abstracts and previews universally accessible we help you purchase only the content that is relevant to you. results, e.g.

CBFA2T2 and C20orf112: two novel fusion partners of RUNX1 in acute myeloid leukemia

Include preview-only content

  1. Article

    Open Access

    Total genomic alteration as measured by SNP-array-based molecular karyoty** is predictive of overall survival in a cohort of MDS or AML patients treated with azacitidine

    Metaphase cytogenetics (MC) has a major role in the risk stratification of patients with myelodysplastic syndromes (MDSs) and can affect the choice of therapies. Azacitidine (AZA) has changed the outcome of pa...

    T Cluzeau, C Moreilhon, N Mounier, J-M Karsenti, L Gastaud… in Blood Cancer Journal (2013)

    Download PDF (277 KB) View Article

  2. Article

    Open Access

    Efficacy and safety of bemcentinib in patients with advanced myelodysplastic neoplasms or acute myeloid leukemia failing hypomethylating agents- the EMSCO phase II BERGAMO trial

    A. S. Kubasch, P. Peterlin, T. Cluzeau, K. S. Götze, K. Sockel, R. Teipel… in Leukemia (2023)

    Download PDF (1384 KB) View Article